Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune system dynamics after inactivated COVID-19 vaccine in healthy volunteers
ChiCTR2100043907Phase 4Recruiting
- Sponsor
- Shanghai East Hospital
- Start
- Dec 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of novel coronavirus inactivated vaccine in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Shanghai East Hospital. Primary endpoints: Neutralizing antibody, Virus-specific antibody and 7 more. Started Dec 2020; status: recruiting.
02
Drugs
novel coronavirus inactivated vaccine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ChiCTR2100043907.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100043907.